346 related articles for article (PubMed ID: 10469794)
1. An update on the therapeutic orphan.
Wilson JT
Pediatrics; 1999 Sep; 104(3 Pt 2):585-90. PubMed ID: 10469794
[No Abstract] [Full Text] [Related]
2. Therapeutic orphans.
Shirkey H
Pediatrics; 1999 Sep; 104(3 Pt 2):583-4. PubMed ID: 10469793
[No Abstract] [Full Text] [Related]
3. Pediatric testing of prescription drugs: the Food and Drug Administration's carrot and stick for the pharmaceutical industry.
Karst KR
Am Univ Law Rev; 2000; 49():739-72. PubMed ID: 11067732
[No Abstract] [Full Text] [Related]
4. Is the "therapeutic orphan" about to be adopted?
Coté CJ; Kauffman RE; Troendle GJ; Lambert GH
Pediatrics; 1996 Jul; 98(1):118-23. PubMed ID: 8668382
[No Abstract] [Full Text] [Related]
5. Pros and cons of off-label promotion investigations and prosecutions.
Loucks MK
Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
[No Abstract] [Full Text] [Related]
6. Is pediatric labeling really necessary?
Christensen ML; Helms RA; Chesney RW
Pediatrics; 1999 Sep; 104(3 Pt 2):593-7. PubMed ID: 10469796
[No Abstract] [Full Text] [Related]
7. The federal preemption debate in pharmaceutical labeling product liability actions.
Gross JM; Curry JA
Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
[No Abstract] [Full Text] [Related]
8. A look at the future of pediatric therapeutics: an investigator's perspective of the new pediatric rule.
Connor JD
Pediatrics; 1999 Sep; 104(3 Pt 2):610-3. PubMed ID: 10469801
[No Abstract] [Full Text] [Related]
9. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
[TBL] [Abstract][Full Text] [Related]
10. Off-label uses of drugs in children.
Blumer JL
Pediatrics; 1999 Sep; 104(3 Pt 2):598-602. PubMed ID: 10469797
[No Abstract] [Full Text] [Related]
11. A survey of developments in food and drug law from July 1998 to November 1999.
Littlefield N; Hada NR
Food Drug Law J; 2000; 55(1):35-56. PubMed ID: 12296348
[No Abstract] [Full Text] [Related]
12. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012.
Cheng CM; Shin J; Guglielmo BJ
JAMA Intern Med; 2014 Oct; 174(10):1704-5. PubMed ID: 25127107
[No Abstract] [Full Text] [Related]
13. Congress, the FDA, and the fair development of new medications for children.
McKinney RE
Pediatrics; 2003 Sep; 112(3 Pt 1):669-70. PubMed ID: 12949299
[No Abstract] [Full Text] [Related]
14. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
[TBL] [Abstract][Full Text] [Related]
15. Should off-label drug use be off-the-table?
Rivkees SA
J Pediatr Endocrinol Metab; 2007 Feb; 20(2):171-2. PubMed ID: 17396432
[No Abstract] [Full Text] [Related]
16. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
[No Abstract] [Full Text] [Related]
17. The dangers of self-dosing.
Schultz S
US News World Rep; 1998 Jul; 125(2):58. PubMed ID: 10181369
[No Abstract] [Full Text] [Related]
18. A strike against preemption.
Nat Biotechnol; 2009 May; 27(5):397. PubMed ID: 19430422
[TBL] [Abstract][Full Text] [Related]
19. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
20. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?
Moxley JH; Yingling GL; Edwards CC
Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
